Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: A Single Photon Emission Computed Tomography study

Journal of Psychopharmacology

Volumn 26, Issue 4, 2012, Pages 452-460

  Kalk, N J ^a   Melichar, J ^b   Holmes, R B ^c   Taylor, L G ^b   Daglish, M R C ^d   Hood, S ^e   Edwards, T ^f   Lennox Smith, A ^g   Lingford Hughes, A R ^a   Nutt, D J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f Dorothy Pattison Hospital   (United Kingdom)

^g PFIZER INC   (United States)

Author keywords

Clonidine; generalized anxiety disorder; neuroimaging; noradrenergic; SPECT

Indexed keywords

CLONIDINE; PAROXETINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; BRAIN PERFUSION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; DRUG DOSE TITRATION; FUSIFORM GYRUS; GENERALIZED ANXIETY DISORDER; HUMAN; MIDDLE FRONTAL GYRUS; NORADRENERGIC SYSTEM; PHARMACOLOGICAL PROCEDURES; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPRAMARGINAL GYRUS; VERBAL BEHAVIOR;

ADULT; AGED; ANXIETY DISORDERS; BRAIN; CEREBROVASCULAR CIRCULATION; CLONIDINE; HUMANS; MEMORY, SHORT-TERM; MIDDLE AGED; RECEPTORS, ADRENERGIC, ALPHA-2; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84860136418     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111415730     Document Type: Article

References (33)

1. Abelson JL, Glitz D, Cameron OG, et al. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Arch Gen Psychiatry. 1991 ; 48: 157-162
2. Arnsten AF. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol. 1997 ; 11: 151-162
3. Audenaert K, Brans B, Van Laere K, Lahorte P, Versijpt J, van Heeringen K, et al. Verbal fluency as a prefrontal activation probe: A validation study using 99mTc-ECD brain SPET. Eur J Nucl Med. 2000 ; 27: 1800-1808
4. Beck A, Steer R Manual for the Beck Anxiety Inventory. San Antonio: Psychological Corporation ; 1990 :
5. Cameron OG, Smith CB, Lee MA, et al. Adrenergic status in anxiety disorders: Platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Biol Psychiatry. 1990 ; 28: 3-20
6. Chamberlain SR, Muller U, Blackwell AD, et al. Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology (Berl). 2006 ; 188: 397-407
7. Charney DS, Woods SW, Heninger GR. Noradrenergic function in generalized anxiety disorder: Effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatry Res. 1989 ; 27: 173-182
8. Coull JT. Modulation of attention by noradrenergic alpha2-agents varies according to arousal level. Drug News Perspect. 2001 ; 14: 5-11
9. Coull JT. Neural correlates of attention and arousal: Insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog Neurobiol. 1998 ; 55: 343-361
10. Coull JT, Middleton HC, Robbins TW, Sahakian BJ. Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology (Berl). 1995 ; 120: 311-321
11. Coull JT, Buchel C, Friston KJ, et al. Noradrenergically mediated plasticity in a human attentional neuronal network. Neuroimage. 1999 ; 10: 705-715
12. Coull JT, Frith CD, Dolan RJ, et al. The neural correlates of the noradrenergic modulation of human attention, arousal and learning. Eur J Neurosci. 1997 ; 9: 589-598
13. Cuenod C, Bookheimer SY, Hertz-Pannier L, Zeffiro TA, Theodore WH, Le Bihan D. Functional MRI during word generation, using conventional equipment: A potential tool for language localization in the clinical environment. Neurology. 1995 ; 45: 1821-1827
14. Frith CD, Friston KJ, Liddle PF, Frackowiak RS. A PET study of word finding. Neuropsychologia. 1991 ; 29: 1137-1148
15. Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activations in PET and fMRI: levels of inference and power'. Neuroimage. 1996 ; 3: 223-235
16. Frith CD, Friston KJ, Liddle PF, Frackowiak RS. A PET study of word finding. Neuropsychologia. 1991 ; 29: 1137-1148
17. Frith CD, Dowdy J, Ferrier IN, Crow TJ. Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine). Psychopharmacology (Berl). 1985 ; 87: 490-493
18. Fu CH, Reed LJ, Meyer JH, et al. Noradrenergic dysfunction in the prefrontal cortex in depression: An [15O] H2O PET study of the neuromodulatory effects of clonidine. Biol Psychiatry. 2001 ; 49: 317-325
19. Giustina A, Buffoli MG, Bussi AR, et al. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy. Horm Metab Res. 1992 ; 24: 240-243
20. Giustina A, Buffoli MG, Bussi AR, et al. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. Horm Res. 1991 ; 36: 192-195
21. Glue P, Wilson S, Ball DM, Nutt DJ. Pharmacology of saccadic eye movements. Psychopharmacology (Berl). 1991 ; 105: 368-373
22. ECDEU Assessment Manual for Psychopharmacology. Guy W, ed. Washington, DC: US Department of Health ; 1976 :
23. Hood SD, Melichar JK, Taylor LG, Kalk N, Edwards TR, Hince DA, et al. Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. J Psychopharmacol. 2011 ; 25: 78-86
24. Jäkkälä P, Riekkinen M, Sirviö J, Koivisto E, Kejonen K, Vanhanen M, et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology. 1999 May ; 20: 460-470
25. Kalk NJ, Nutt DJ, Lingford-Hughes AR. The role of central noradrenergic dysregulation in anxiety disorders: Evidence from clinical studies. J Psychopharmacol. 2011 ; 25: 3-16
26. Kendler K, Gardner CO, Gatz M, Pedersen NL. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med. 2007 ; 37: 453-462
27. Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med. 2008 ; 38: 365-374
28. Moffoot A, O'Carroll RE, Murray C, et al. Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis. Psychol Med. 1994 ; 24: 53-61
29. Nutt DJ, Ballinger JC Anxiety Disorders. Oxford: Blackwell Publishing ; 2005 :
30. Schlosser R, Hutchinson M, Joseffer S, Rusinek H, Saarimaki A, Stevenson J, et al. Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry. 1998 ; 64: 492-498
31. Sheehan DV, Lecrubier Y, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998 ; 59: 22-33
32. Spielberger C, Gorsuch RI, Lushene PR, Vagg PR, Jacobs AG Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press, Inc ; 1983 :
33. Wellcome Department of Imaging Neuroscience/Institute of Neurology, Statistical Parametric Mapping Software, London, UK (1994-2007). Available at: http://www.fil.ion.ucl.ac.uk/spm/ (accessed November 2007).